In Vivo Proviral Burden and Viral Rna Expression in T Cell Subsets of Patients with Human T Lymphotropic Virus Type-1-Associated Myelopathy/Tropical Spastic Paraparesis

Isamu Cho First Department of Internal Medicine, Kumamoto University School of Medicine, Department of Medicine, Kumamoto City Hospital, Honjo, Kumamoto, Japan

Search for other papers by Isamu Cho in
Current site
Google Scholar
PubMed Close
,
Mineharu Sugimoto First Department of Internal Medicine, Kumamoto University School of Medicine, Department of Medicine, Kumamoto City Hospital, Honjo, Kumamoto, Japan

Search for other papers by Mineharu Sugimoto in
Current site
Google Scholar
PubMed Close
,
Shuji Mita First Department of Internal Medicine, Kumamoto University School of Medicine, Department of Medicine, Kumamoto City Hospital, Honjo, Kumamoto, Japan

Search for other papers by Shuji Mita in
Current site
Google Scholar
PubMed Close
,
Makoto Tokunaga First Department of Internal Medicine, Kumamoto University School of Medicine, Department of Medicine, Kumamoto City Hospital, Honjo, Kumamoto, Japan

Search for other papers by Makoto Tokunaga in
Current site
Google Scholar
PubMed Close
,
Fumiya Imamura First Department of Internal Medicine, Kumamoto University School of Medicine, Department of Medicine, Kumamoto City Hospital, Honjo, Kumamoto, Japan

Search for other papers by Fumiya Imamura in
Current site
Google Scholar
PubMed Close
, and
Masayuki Ando First Department of Internal Medicine, Kumamoto University School of Medicine, Department of Medicine, Kumamoto City Hospital, Honjo, Kumamoto, Japan

Search for other papers by Masayuki Ando in
Current site
Google Scholar
PubMed Close
DOI:
https://doi.org/10.4269/ajtmh.1995.53.412
Volume/Issue:
Volume 53: Issue 4
Page(s):
412–418
Restricted access
Get Permissions

We used in situ hybridization combined with immunocytochemistry, cell sorting, and the polymerase chain reaction (PCR) to investigate clinical events in three asymptomatic carriers of human T lymphotrophic virus type-1 (HTLV-1) and ten patients with HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). The objective was to determine which T cell subset of peripheral blood mononuclear cells (PBMC), CD4 or CD8, were infected by HTLV-1 and the manner in which HTLV-1 proviral DNA was expressed at the level of the single cell. Both CD4-positive and CD8-positive cells of the PBMC from five patients with HAM/TSP were infected with HTLV-1. The proportion of HTLV-1-infected cells was 2.5–40% in the CD4-positive subset and 1.0–65% in the CD8-positive subset, when quantified by PCR using HTLV-1-infected MT2 cells as a positive standard. Proviral DNA of HTLV-1 was expressed in both CD4-positive cells and CD8-positive cells of the PBMC from six patients with HAM/TSP and three asymptomatic HTLV-1 carriers. In patients with HAM/TSP, the proportion of the cells expressing HTLV-1 proviral DNA was 0.02–0.1% in both subsets. In asymptomatic carriers, the expression of HTLV-1 proviral DNA was 0.01–0.02% in the CD4-positive subset and 0.01% in the CD8-positive subset. Therefore, HTLV-1 possessed similar in vivo cellular tropism for both CD4-positive cells and CD8-positive cells and HTLV-1 proviral DNA was expressed in vivo in both circulating T cell subsets. These results suggest that the immunologic states of patients with HAM/TSP are modulated by the viral gene expression in both T cell subsets.
Copyright:
Copyright © 1995 by The American Society of Tropical Medicine and Hygiene 1995
Published Online:
Oct 1995
Cover The American Journal of Tropical Medicine and Hygiene
The American Journal of Tropical Medicine and Hygiene
Print ISSN:
0002-9637
Past two years Past Year Past 30 Days
Abstract Views 281 102 3
Full Text Views 13 1 1
PDF Downloads 10 1 1
 
Membership Banner
 
 
 
Affiliate Membership Banner
 
 
Research for Health Information Banner
 
 
CLOCKSS
 
 
 
Society Publishers Coalition Banner
Save